Cancer Research: DNA Repair Mechanism Further Elucidated
“The findings from our work provide the basis for new approaches to treating various types of cancer”
Researchers at the University of Würzburg, led by Caroline Kisker in cooperation with Claudia Höbartner, discovered how the protein XPD detects a severe DNA damage and controls its repair.
The XPD protein is a central component of our body's own 'DNA repair team', known as nucleotide excision repair (NER). Like a sniffer dog, NER detects marked areas of damage, tracks down the damaged DNA and recruits other repair proteins to cut out and replace the defective sections. In healthy people, for example, XPD prevents the development of skin cancer by detecting and repairing UV-damaged DNA.
A team of researchers at the University of Würzburg (JMU) has now discovered for the first time exactly how the XPD protein is able to detect and verify the presence of a DNA damage. The team was led by the biochemist Caroline Kisker, Chair of Structural Biology at the Rudolf Virchow Centre in Würzburg, in collaboration with the chemist Claudia Höbartner from the Department of Organic Chemistry.
Study of Severe DNA Damage
The Würzburg team focused on how the XPD protein works in interstrand crosslinking – one of the most severe forms of DNA damage known. It is caused, for example, by environmental toxins and industrial chemicals. “Interstrand crosslinking causes DNA to be incorrectly copied and read during cell division”, explains Caroline Kisker. “This leads to genetic damage that can trigger cancer.”
In their study, the scientists used cryo-electron microscopy to analyse how XPD unwinds the double helix of DNA to reveal the defective sites of interstrand cross-linking, and created a model of how the damage is detected and removed. “The findings from our work provide the basis for new approaches to treating various types of cancer”, says Jochen Kuper, employee in Kisker's team. “By specifically weakening repair mechanisms such as NER in cancer cells, we could significantly increase the effectiveness of drugs.”
In further studies, the research team plans to investigate how XPD detects various other types of DNA damage. The research was funded by the German Research Foundation (DFG) and German Cancer Aid.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
